BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 27, Issue 48
  • This Article
Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (10806)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.
Item 
Count 
PDF713
WORD117
HTML6166
Figures (1-1)1113
Tables (1-1)632
 Sum=8741
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse581
Download1487
 Sum=2068
Dec 28, 2021 (publication date) through Nov 28, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review
Copyright ©The Author(s) 2021.
World J Gastroenterol. Dec 28, 2021; 27(48): 8242-8261
Published online Dec 28, 2021. doi: 10.3748/wjg.v27.i48.8242
Table 1 Phase of clinical trials for emerging therapeutic options for inflammatory bowel
Treatment
UC
CD
Treatment
UC
CD
Treatment
UC
CD
Treatment
UC
CD
Anti-ILAnti-integrinJAK inhibitorsOther therapies
RizankinumabIIIIIIOntamalimabIIIIIUpadacitinibIIIIIIAVX-470 I
MirikizumabIIIIIEtrolizumabIIIIIIFilgotinibIIIIIILaquinimod-II
BrazikumabIIIIIAbrilumabIIIIPeficitinibII-CobitolimodIII-
GuselkumabIIIIIAJM300III-TD-1473IIIIBL-7040II-
Briakinumab-IICytokine blockadeModulation of SIP1PhosphatidylcholineIII-
PTG‑200-IIVercirnon -IIIOzanimodIIIIIIApremilastII-
Secukinumab-IIEldelumabIIIIEtrasimodIII-Mongersen-II
Brodalumab-IIGSK3050002I-Amiselimod-IIGATA3 DNAzymeII-
PF-04236921-IIKRP-203II-STNM01II
UC: Ulcerative colitis; CD: Crohn´s disease; IL: Interleukin; JAK: Janus kinase; S1P1: Sphingosine-1-phosphate.
Full Size Table
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345